Condensed Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2017	Sep. 30, 2016
Equity Method Investment, Realized Gain (Loss) on Disposal	$ 0.0	$ (398.0)
Cash flows from operating activities:
Net earnings	855.2	1,289.9
Discontinued operations, net of tax	(5.5)	(34.3)
Adjustments for non-cash transactions:
Asset impairment	(8.4)	0.0
Depreciation and amortization	261.9	264.7
Changes in assets and liabilities, net	(391.0)	(198.3)
Other non-cash items, net	163.3	98.4
Net cash provided by (used in) continuing operating activities	890.8	1,022.6
Net cash provided by (used in) discontinued operating activities	(17.6)	94.1
Net cash provided by (used in) operating activities	873.2	1,116.7
Cash flows from investing activities:
Capital expenditures	(149.9)	(127.5)
Acquisition of businesses, net of cash acquired	(60.3)	(9.2)
Proceeds from sale of property, plant and equipment	1.1	2.6
Proceeds from Sale of Equity Method Investments	0.0	423.0
Net cash provided by (used in) continuing investing activities	(206.4)	288.4
Cash flows from financing activities:
Short-term borrowings (payments), net	(11.6)	(150.6)
Net proceeds (repayments) in debt	(11.6)	(150.6)
Dividends paid to ordinary shareholders	(318.0)	(245.6)
Dividends paid to noncontrolling interests	(15.5)	(13.8)
Repurchase of ordinary shares	(911.1)	(250.1)
Other, net	40.7	16.3
Net cash provided by (used in) continuing financing activities	(1,222.5)	(645.9)
Effect of exchange rate changes on cash and cash equivalents	100.0	8.6
Net increase (decrease) in cash and cash equivalents	(455.7)	767.8
Cash and cash equivalents - beginning of period	1,714.7	736.8
Cash and cash equivalents - end of period	$ 1,259.0	$ 1,504.6